SLC2A9 Is a High-Capacity Urate Transporter in Humans

• Mark J Caulfield ,

  Contributed equally to this work with: Mark J Caulfield, Patricia B Munroe

  *To whom correspondence should be addressed. E-mail: m.j.caulfield@qmul.ac.uk

  Affiliation Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom

  ⨯
• Patricia B Munroe ,

  Contributed equally to this work with: Mark J Caulfield, Patricia B Munroe

  Affiliation Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom

  ⨯
• Deb O'Neill,

  Affiliation Department of Physiology, University of Alberta, Edmonton, Alberta, Canada

  ⨯
• Kate Witkowska,

  Affiliation Department of Physiology, University of Alberta, Edmonton, Alberta, Canada

  ⨯
• Fadi J Charchar,

  Affiliation Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom

  ⨯
• Manuel Doblado,

  Affiliation Department of Obstetrics and Gynaecology, Washington University in St Louis School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Sarah Evans,

  Affiliation Department of Obstetrics and Gynaecology, Washington University in St Louis School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Susana Eyheramendy,

  Affiliation Department of Statistics, Pontificia Universidad Católica de Chile, Santiago, Chile

  ⨯
• Abiodun Onipinla,

  Affiliation Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom

  ⨯
• Philip Howard,

  Affiliation Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom

  ⨯
• Sue Shaw-Hawkins,

  Affiliation Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom

  ⨯
• Richard J Dobson,

  Affiliation Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom

  ⨯
• Chris Wallace,

  Affiliation Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom

  ⨯
• Stephen J Newhouse,

  Affiliation Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom

  ⨯
• Morris Brown,

  Affiliation Clinical Pharmacology Unit, University of Cambridge, Addenbrookes Hospital, Cambridge, United Kingdom

  ⨯
• John M Connell,

  Affiliation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Anna Dominiczak,

  Affiliation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom

  ⨯
• Martin Farrall,

  Affiliation Cardiovascular Medicine, University of Oxford, Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom

  ⨯
• G. Mark Lathrop,

  Affiliation Centre National de Génotypage, Evry, France

  ⨯
• Nilesh J Samani,

  Affiliations Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, United Kingdom , Epidemiology and Public Health, University College, London, United Kingdom

  ⨯
• Meena Kumari,

  Affiliation Epidemiology and Public Health, University College, London, United Kingdom

  ⨯
• Michael Marmot,

  Affiliation Epidemiology and Public Health, University College, London, United Kingdom

  ⨯
• Eric Brunner,

  Affiliation Epidemiology and Public Health, University College, London, United Kingdom

  ⨯
• John Chambers,

  Affiliation National Heart Lung Institute and Epidemiology and Public Health, Imperial College, London, United Kingdom

  ⨯
• Paul Elliott,

  Affiliation National Heart Lung Institute and Epidemiology and Public Health, Imperial College, London, United Kingdom

  ⨯
• Jaspal Kooner,

  Affiliation National Heart Lung Institute and Epidemiology and Public Health, Imperial College, London, United Kingdom

  ⨯
• Maris Laan,

  Affiliation Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia

  ⨯
• Elin Org,

  Affiliation Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia

  ⨯
• Gudrun Veldre,

  Affiliations Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia , Department of Cardiology, University of Tartu, Tartu, Estonia

  ⨯
• Margus Viigimaa,

  Affiliation Centre of Cardiology, North Estonia Medical Centre, Tallinn, Estonia

  ⨯
• Francesco P Cappuccio,

  Affiliation Cardiovascular Medicine and Epidemiology, Clinical Sciences Research Institute, University of Warwick Medical School, Clifford Bridge Road, Coventry, United Kingdom

  ⨯
• Chen Ji,

  Affiliation Cardiovascular Medicine and Epidemiology, Clinical Sciences Research Institute, University of Warwick Medical School, Clifford Bridge Road, Coventry, United Kingdom

  ⨯
• Roberto Iacone,

  Affiliation Department of Clinical and Experimental Medicine, Federico II University of Naples Medical School, Naples, Italy

  ⨯
• Pasquale Strazzullo,

  Affiliation Department of Clinical and Experimental Medicine, Federico II University of Naples Medical School, Naples, Italy

  ⨯
• Kelle H Moley,

  Affiliation Department of Obstetrics and Gynaecology, Washington University in St Louis School of Medicine, St. Louis, Missouri, United States of America

  ⨯
•  [ ... ],
• Chris Cheeseman

  Affiliation Department of Physiology, University of Alberta, Edmonton, Alberta, Canada

  ⨯
• [ view all ]
• [ view less ]